ID30131A - USE OF CHOLESTEROL - Google Patents

USE OF CHOLESTEROL

Info

Publication number
ID30131A
ID30131A IDW00200101666A ID20011666A ID30131A ID 30131 A ID30131 A ID 30131A ID W00200101666 A IDW00200101666 A ID W00200101666A ID 20011666 A ID20011666 A ID 20011666A ID 30131 A ID30131 A ID 30131A
Authority
ID
Indonesia
Prior art keywords
cholesterol
Prior art date
Application number
IDW00200101666A
Other languages
Indonesian (id)
Inventor
Ali Raza
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26315084&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID30131(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9902590.0A external-priority patent/GB9902590D0/en
Priority claimed from GBGB9921062.7A external-priority patent/GB9921062D0/en
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of ID30131A publication Critical patent/ID30131A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
IDW00200101666A 1999-02-06 2000-02-01 USE OF CHOLESTEROL ID30131A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9902590.0A GB9902590D0 (en) 1999-02-06 1999-02-06 Use of cholesterol-lowering agent
GBGB9921062.7A GB9921062D0 (en) 1999-09-08 1999-09-08 Use of cholestrol-lowering agent

Publications (1)

Publication Number Publication Date
ID30131A true ID30131A (en) 2001-11-08

Family

ID=26315084

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW00200101666A ID30131A (en) 1999-02-06 2000-02-01 USE OF CHOLESTEROL

Country Status (22)

Country Link
EP (1) EP1150679A1 (en)
JP (2) JP2002536333A (en)
KR (1) KR100699287B1 (en)
CN (1) CN1347320A (en)
AR (1) AR022462A1 (en)
AU (1) AU769897B2 (en)
BR (1) BR0007991A (en)
CA (1) CA2358641A1 (en)
CZ (1) CZ20012631A3 (en)
EE (1) EE04659B1 (en)
HK (1) HK1040924A1 (en)
HU (1) HUP0105019A3 (en)
ID (1) ID30131A (en)
IL (1) IL144662A0 (en)
IS (1) IS5996A (en)
MY (1) MY136382A (en)
NO (1) NO319827B1 (en)
NZ (1) NZ512681A (en)
PL (1) PL349137A1 (en)
SK (1) SK11112001A3 (en)
TR (1) TR200102236T2 (en)
WO (1) WO2000045819A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0001621D0 (en) 2000-01-26 2000-03-15 Astrazeneca Ab Pharmaceutical compositions
GB0003305D0 (en) 2000-02-15 2000-04-05 Zeneca Ltd Pyrimidine derivatives
SE0103509D0 (en) * 2001-10-19 2001-10-19 Astrazeneca Ab Rosuvastatin in pre-demented states
GB0322552D0 (en) 2003-09-26 2003-10-29 Astrazeneca Uk Ltd Therapeutic treatment
WO2007142581A1 (en) * 2006-06-07 2007-12-13 Astrazeneca Ab Combination product for the treatment or prevention of dyslipidaemia
US8293721B2 (en) 2007-06-20 2012-10-23 Merck Sharpe & Dohme Corp. CETP inhibitors derived from benzoxazole arylamides
WO2008156715A1 (en) 2007-06-20 2008-12-24 Merck & Co., Inc. Cetp inhibitors derived from benzoxazole arylamides
US8436028B2 (en) 2007-06-20 2013-05-07 Merck Sharp & Dohme Corp CETP inhibitors derived from benzoxazole arylamides
EP2216095A1 (en) * 2009-01-27 2010-08-11 Koninklijke Philips Electronics N.V. Microfluidic device for full blood count

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260446A (en) * 1989-12-22 1993-11-09 Basf Aktiengesellschaft Aminothiazoles
JP2648897B2 (en) * 1991-07-01 1997-09-03 塩野義製薬株式会社 Pyrimidine derivatives

Also Published As

Publication number Publication date
NO20013810D0 (en) 2001-08-03
KR20010089631A (en) 2001-10-06
CA2358641A1 (en) 2000-08-10
AU769897B2 (en) 2004-02-05
AU2305100A (en) 2000-08-25
EP1150679A1 (en) 2001-11-07
JP2011137023A (en) 2011-07-14
HK1040924A1 (en) 2002-06-28
AR022462A1 (en) 2002-09-04
EE200100404A (en) 2002-10-15
NZ512681A (en) 2003-12-19
NO20013810L (en) 2001-10-03
IS5996A (en) 2001-07-10
SK11112001A3 (en) 2002-02-05
BR0007991A (en) 2001-11-06
HUP0105019A3 (en) 2003-02-28
TR200102236T2 (en) 2001-12-21
WO2000045819A1 (en) 2000-08-10
PL349137A1 (en) 2002-07-01
MY136382A (en) 2008-09-30
CZ20012631A3 (en) 2001-10-17
KR100699287B1 (en) 2007-03-26
JP2002536333A (en) 2002-10-29
CN1347320A (en) 2002-05-01
NO319827B1 (en) 2005-09-19
HUP0105019A2 (en) 2002-05-29
IL144662A0 (en) 2002-05-23
EE04659B1 (en) 2006-08-15

Similar Documents

Publication Publication Date Title
DE60043764D1 (en) disposable diaper
DE60021475D1 (en) disposable diaper
ID25792A (en) ANTIBODIES OF HUMAN CD40
NO20014379D0 (en) Use of Xenon for the Treatment of Neurointoxics
DE60018509D1 (en) disposable diaper
DE60022437D1 (en) disposable diaper
FI20000863A (en) New treatment procedure
DE50004193D1 (en) MEDICAL INSTRUMENT
NO20014490L (en) Medical mixtures
DE60024528D1 (en) disposable diaper
DE60030399D1 (en) disposable diaper
DE60025453D1 (en) disposable diaper
DE60014751D1 (en) disposable diaper
DE60026784D1 (en) disposable diaper
DE60039211D1 (en) disposable diaper
ID30131A (en) USE OF CHOLESTEROL
DE60018342D1 (en) disposable diaper
ID30381A (en) USE OF ARILALKANOILPIRIDAZINA
FI991256A0 (en) Serving aid
PT1232141E (en) ETERIES OF O-DESMETIL-VENLAFAXIN
ATA203199A (en) PROCEDURE
SE9901120D0 (en) New human enzyme
SE9900032D0 (en) Use of biocontrol agent
SE9904262D0 (en) Perineometer for clinical and domestic use
IT246900Y1 (en) STRUCTURE OF BARBECUE FOR SIMPLIFIED USE